International clinical trial to test the use of dye during children’s cancer surgery
Testing whether a dye called Indocyanine Green (ICG) can help surgeons identify tumours and lymph nodes during surgery.
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Testing whether a dye called Indocyanine Green (ICG) can help surgeons identify tumours and lymph nodes during surgery.
Investigating how antibody immunotherapy causes pain and nerve damage.
Finding which MEK inhibitors work best for children with acute myeloid leukaemia.
Using a new way to measure genetic variation in key sections of noncoding DNA.
Assessing whether blocking a protein's activity could improve survival and reduce side effects.
Finding why immunotherapy doesn't work for some children with sarcoma tumours.
Finding drugs which target genes that drive high-risk acute lymphoblastic leukaemia.
Understanding how proteins act inside acute myeloid leukaemia cells, to find new drug targets.
Looking at the genetics of bone marrow samples to see which genes affect resistance to treatment.